This video from @NHSEngland on caredata is good: http://www.england.nhs.uk/ourwork/tsd/care-data/ … Maybe another on objections & misconceptions?
-
-
Replying to @harrylongman
.
@harrylongman@NHSEngland The problem is partly one of vague future benefits versus real risks.5 replies 1 retweet 2 likes -
Replying to @JeremyTaylorNV
@JeremyTaylorNV@harrylongman@nhsengland Jeremy, how is transparency of outcomes in primary care a vague benefit?3 replies 0 retweets 0 likes -
Replying to @tkelsey1
.
@tkelsey1@harrylongman "Give me your personal data so I can improve transparency of outcomes in primary care". Great aim, not a great sell2 replies 0 retweets 0 likes -
Replying to @JeremyTaylorNV2 replies 0 retweets 0 likes
-
Replying to @tkelsey1
@tkelsey1@Jarmann Do things like this, which@PaulbernalUK sent me, not concern you Tim? > http://www.cs.utexas.edu/~shmat/shmat_oak08netflix.pdf …3 replies 1 retweet 0 likes -
Replying to @C7RKY
.
@C7RKY@tkelsey1@PaulbernalUK They are a concern, even if it’s illegal with care.data. All those problems are avoided with informed opt-in2 replies 1 retweet 0 likes
.@Jarmann @tkelsey1 @PaulbernalUK A big concern, I agree. Corporations, inc pharma, tend to have a 'flexible attitude' towards what's legal.
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.